AOST

Prix: GRATUIT Catégorie: Médecine Non évaluée Date de publication: 22 juillet 2014

Société: Outsourcing Development Taille: 35.59 MB Version: 1.0.3.3200 Type d’appli: iPad

Description

Cardiovascular diseases remain the number one cause of death in Belgium. Cardiovascular risk is influenced amongst others by age, sex, family history, smoking, blood pressure and cholesterol. AOST® focuses on the influence of cholesterol on cardiovascular risk.
The application allows a physician
- to calculate the cardiovascular risk of his patient (SCORE)
- to motivate his patient to treat to LDL target by demonstrating the effect of lowering cholesterol on cardiovascular risk
- to optimize the treatment of a patient by predicting the theoretical LDL-decrease of different therapeutic approaches.



THE INFORMATION PROVIDED BY THIS MEDICAL DEVICE IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT in any manner. The User is hereby notified that the information contained herein may not meet the user's needs. The User of this software assumes sole responsibility for any decisions made or actions taken based on the information contained in AOST®. Neither MSD Belgium bvba/sprl, the system's author nor any other party involved in the preparation, publication or distribution of AOST, shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any User's use of or reliance upon this system and the information contained within. MSD Belgium bvba/sprl disclaims all warranties regarding such information whether express or implied, including any warranty as to the quality, accuracy, currency or suitability of this information for any particular purpose. MSD Belgium bvba/sprl and the system's authors, developers and distributors assume no responsibility for any erroneous results due to defects in the system. ACCESS TO AND USE OF AOST © IS PROVIDED WITHOUT WARRANTY OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OR ANY OTHER WARRANTY, EXPRESS OR IMPLIED. AOST is the project name of the Class IIa medical device CRETHSOFT and has obtained a CE label for use within the European Union.